EWS
ARKG icon

Eagle Wealth Strategies’s ARK Genomic Revolution ETF ARKG Stock Holding History

Eagle Wealth Strategies’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Buy
+5,964
New +$190K 0.1% 96
2024
Q4 		– Sell
-10,592
Closed -$271K – 106
2024
Q3 		$271K Sell
10,592
-3,530
-25% -$89.9K 0.2% 85
2024
Q2 		$332K Buy
14,122
+1,676
+13% +$42.3K 0.27% 59
2024
Q1 		$353K Buy
12,446
+1,830
+17% +$55K 0.29% 59
2023
Q4 		$348K Buy
+10,616
New +$289K 0.21% 59

Other funds holding ARKG

MFPI
Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM
CIC
Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CFIM
Client First Investment Management West Bend, Wisconsin $237M AUM 90.28% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
SFC
Strategic Financial Concepts San Antonio, Texas $336M AUM 22.98% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Eagle Wealth Strategies's ARKG Position: Q2 2026 in Review

Eagle Wealth Strategies opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 5,964 shares worth $251K. The stake represents 0.1% of the portfolio and ranks #96 among its holdings. This is a return to the name: Eagle Wealth Strategies previously reported a position in ARKG as recently as Q3 2024.

Eagle Wealth Strategies first reported a position in ARKG in Q4 2023 and has held it in 5 quarters since. The position peaked at $353K in Q1 2024. 99 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Eagle Wealth Strategies held 5,964 shares of ARK Genomic Revolution ETF worth $251K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new Eagle Wealth Strategies position in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.1% of Eagle Wealth Strategies's portfolio in Q2 2026, its #96 holding.
  • Eagle Wealth Strategies first reported a position in ARK Genomic Revolution ETF in Q4 2023 and has held it in 5 quarters since.
  • Eagle Wealth Strategies's ARK Genomic Revolution ETF position peaked at $353K in Q1 2024.
  • 99 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Eagle Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.